Literature DB >> 21576509

Cutting edge: Human regulatory T cells require IL-35 to mediate suppression and infectious tolerance.

Vandana Chaturvedi1, Lauren W Collison, Clifford S Guy, Creg J Workman, Dario A A Vignali.   

Abstract

Human regulatory T cells (T(reg)) are essential for the maintenance of immune tolerance. However, the mechanisms they use to mediate suppression remain controversial. Although IL-35 has been shown to play an important role in T(reg)-mediated suppression in mice, recent studies have questioned its relevance in human T(reg). In this study, we show that human T(reg) express and require IL-35 for maximal suppressive capacity. Substantial upregulation of EBI3 and IL12A, but not IL10 and TGFB, was observed in activated human T(reg) compared with conventional T cells (T(conv)). Contact-independent T(reg)-mediated suppression was IL-35 dependent and did not require IL-10 or TGF-β. Lastly, human T(reg)-mediated suppression led to the conversion of the suppressed T(conv) into iTr35 cells, an IL-35-induced T(reg) population, in an IL-35-dependent manner. Thus, IL-35 contributes to human T(reg)-mediated suppression, and its conversion of suppressed target T(conv) into IL-35-induced T(reg) may contribute to infectious tolerance.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21576509      PMCID: PMC3110563          DOI: 10.4049/jimmunol.1100315

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  19 in total

1.  Generation of potent and stable human CD4+ T regulatory cells by activation-independent expression of FOXP3.

Authors:  Sarah E Allan; Alicia N Alstad; Natacha Merindol; Natasha K Crellin; Mario Amendola; Rosa Bacchetta; Luigi Naldini; Maria Grazia Roncarolo; Hugo Soudeyns; Megan K Levings
Journal:  Mol Ther       Date:  2007-11-06       Impact factor: 11.454

2.  Infectious immunological tolerance.

Authors:  R K Gershon; K Kondo
Journal:  Immunology       Date:  1971-12       Impact factor: 7.397

3.  In vitro expanded human CD4+CD25+ regulatory T cells suppress effector T cell proliferation.

Authors:  K E Earle; Q Tang; X Zhou; W Liu; S Zhu; M L Bonyhadi; J A Bluestone
Journal:  Clin Immunol       Date:  2005-04       Impact factor: 3.969

Review 4.  How regulatory T cells work.

Authors:  Dario A A Vignali; Lauren W Collison; Creg J Workman
Journal:  Nat Rev Immunol       Date:  2008-07       Impact factor: 53.106

5.  Human CD4+ CD25+ Foxp3+ regulatory T cells do not constitutively express IL-35.

Authors:  Emilie Bardel; Frédérique Larousserie; Pascaline Charlot-Rabiega; Aurore Coulomb-L'Herminé; Odile Devergne
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

6.  The inhibitory cytokine IL-35 contributes to regulatory T-cell function.

Authors:  Lauren W Collison; Creg J Workman; Timothy T Kuo; Kelli Boyd; Yao Wang; Kate M Vignali; Richard Cross; David Sehy; Richard S Blumberg; Dario A A Vignali
Journal:  Nature       Date:  2007-11-22       Impact factor: 49.962

Review 7.  T regulatory cells in autoimmune diabetes: past challenges, future prospects.

Authors:  Jeffrey A Bluestone; Qizhi Tang; Caitlin E Sedwick
Journal:  J Clin Immunol       Date:  2008-08-21       Impact factor: 8.317

Review 8.  Infectious tolerance and the long-term acceptance of transplanted tissue.

Authors:  Herman Waldmann; Elizabeth Adams; Paul Fairchild; Stephen Cobbold
Journal:  Immunol Rev       Date:  2006-08       Impact factor: 12.988

9.  Infectious tolerance: human CD25(+) regulatory T cells convey suppressor activity to conventional CD4(+) T helper cells.

Authors:  Helmut Jonuleit; Edgar Schmitt; Hacer Kakirman; Michael Stassen; Jürgen Knop; Alexander H Enk
Journal:  J Exp Med       Date:  2002-07-15       Impact factor: 14.307

10.  CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production.

Authors:  A M Thornton; E M Shevach
Journal:  J Exp Med       Date:  1998-07-20       Impact factor: 14.307

View more
  83 in total

Review 1.  A cytokine-centric view of the pathogenesis and treatment of autoimmune arthritis.

Authors:  Brian Astry; Erin Harberts; Kamal D Moudgil
Journal:  J Interferon Cytokine Res       Date:  2011-12       Impact factor: 2.607

Review 2.  Regulatory immune cells in transplantation.

Authors:  Kathryn J Wood; Andrew Bushell; Joanna Hester
Journal:  Nat Rev Immunol       Date:  2012-05-25       Impact factor: 53.106

3.  Polyclonal CD4+Foxp3+ Treg cells induce TGFβ-dependent tolerogenic dendritic cells that suppress the murine lupus-like syndrome.

Authors:  Qin Lan; Xiaohui Zhou; Huimin Fan; Maogen Chen; Julie Wang; Bernhard Ryffel; David Brand; Rajalakshmy Ramalingam; Pawel R Kiela; David A Horwitz; Zhongmin Liu; Song Guo Zheng
Journal:  J Mol Cell Biol       Date:  2012-07-06       Impact factor: 6.216

4.  CD4+VEGFR1(HIGH) T cell as a novel Treg subset regulates inflammatory bowel disease in lymphopenic mice.

Authors:  Jin-Young Shin; Il-Hee Yoon; Jong-Hyung Lim; Jun-Seop Shin; Hye-Young Nam; Yong-Hee Kim; Hyoung-Soo Cho; So-Hee Hong; Jung-Sik Kim; Won-Woo Lee; Chung-Gyu Park
Journal:  Cell Mol Immunol       Date:  2015-07-27       Impact factor: 11.530

5.  Phenotype and function of regulatory T cells in the genital tract.

Authors:  Janina Jiang; Kathleen A Kelly
Journal:  Curr Trends Immunol       Date:  2011

6.  Assessing the role of IL-35 in colorectal cancer progression and prognosis.

Authors:  Jin-Cheng Zeng; Zhi Zhang; Tian-Yu Li; Yan-Fang Liang; Hong-Mei Wang; Jing-Jing Bao; Jun-Ai Zhang; Wan-Dang Wang; Wen-Yu Xiang; Bin Kong; Zhi-Yong Wang; Bin-Hua Wu; Xiao-Dong Chen; Long He; Shu Zhang; Cong-Yi Wang; Jun-Fa Xu
Journal:  Int J Clin Exp Pathol       Date:  2013-08-15

7.  Levels of interleukin-35 and its relationship with regulatory T-cells in chronic hepatitis B patients.

Authors:  Yin-yue Shi; Ming-jia Dai; Gui-ping Wu; Pei-pei Zhou; Yuan Fang; Xue-bing Yan
Journal:  Viral Immunol       Date:  2014-12-10       Impact factor: 2.257

8.  Plasma Level of Interleukin-35 as an Independent Prognostic Indicator in Hepatocellular Carcinoma.

Authors:  Xiangting Qiu; Xinhua Wang; Yucui Song; Lingling Chen
Journal:  Dig Dis Sci       Date:  2016-10-03       Impact factor: 3.199

9.  The B10 Idd9.3 locus mediates accumulation of functionally superior CD137(+) regulatory T cells in the nonobese diabetic type 1 diabetes model.

Authors:  Kritika Kachapati; David E Adams; Yuehong Wu; Charles A Steward; Daniel B Rainbow; Linda S Wicker; Robert S Mittler; William M Ridgway
Journal:  J Immunol       Date:  2012-10-12       Impact factor: 5.422

10.  Interleukin-35 upregulates OPG and inhibits RANKL in mice with collagen-induced arthritis and fibroblast-like synoviocytes.

Authors:  Y Li; D Li; Y Li; S Wu; S Jiang; T Lin; L Xia; H Shen; J Lu
Journal:  Osteoporos Int       Date:  2015-11-16       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.